A study on the effectiveness of multiple intraoperative disinfections and bacteriological monitoring in reducing postoperative intracranial infection rates in transnasal endoscopic skull base surgery - Scorecard - MDSpire
Advertisement
A study on the effectiveness of multiple intraoperative disinfections and bacteriological monitoring in reducing postoperative intracranial infection rates in transnasal endoscopic skull base surgery
Clinical Scorecard: Impact of Intraoperative Disinfection Methods and Bacteriological Surveillance on Postoperative Intracranial Infection Rates Following Transnasal Endoscopic Skull Base Surgery
At a Glance
Category
Detail
Condition
Postoperative intracranial infections after transnasal endoscopic skull base surgery (TESBS)
Key Mechanisms
Bacterial colonization of nasal and sinus cavities leading to intracranial infection via surgical passage; effectiveness of multiple intraoperative sinus cavity disinfections in reducing bacterial load
Target Population
Patients undergoing transnasal endoscopic skull base surgery for pituitary adenomas, craniopharyngiomas, meningiomas, chordomas, nerve sheath tumors, and other skull base diseases
Care Setting
Neurosurgical operating rooms and postoperative care units in tertiary hospital settings
Key Highlights
TESBS traverses bacterially colonized nasal and sinus cavities, increasing risk of postoperative intracranial infections.
Multiple intraoperative disinfection steps with complex iodine significantly reduce postoperative intracranial infection rates compared to routine single preoperative nasal disinfection.
Intraoperative bacteriological surveillance identifies colonizing bacteria and informs targeted infection control strategies.
Guideline-Based Recommendations
Diagnosis
Monitor for unexplained fever, intracranial hypertension, and meningeal irritation symptoms postoperatively.
Perform cerebrospinal fluid (CSF) analysis showing turbid appearance, protein > 2200 mg/L, WBC > 10 × 10^6/L, glucose < 2.2 mmol/L, or CSF glucose/serum glucose ratio ≤ 0.4.
Confirm diagnosis with positive microbiological cultures from CSF, drainage tubes, implants, or specimen smears.
Management
Implement multiple intraoperative sinus cavity disinfections using complex iodine at defined surgical stages: preoperative nasal mucosa contraction, sphenoid sinus exposure, and dura exposure.
Continue standard postoperative care with vigilance for infection signs.
Monitoring & Follow-up
Conduct intraoperative bacteriological surveillance by sampling nasal vestibule, sphenoid sinus mucosa, skull base dura before and after disinfection, and intracranial cavity before saline rinse.
Use automated bacterial identification and drug sensitivity testing (e.g., VITEK2-compact) to guide antimicrobial therapy.
Risks
CSF leakage is a significant risk factor for postoperative intracranial infection.
Colonization by non-pathogenic nasopharyngeal bacteria such as Streptococcus pneumoniae, Staphylococcus epidermidis, Klebsiella pneumoniae, and Haemophilus influenzae can lead to infection.
Patient & Prescribing Data
1002 TESBS patients aged 4 to 82 years with various skull base pathologies
Multiple disinfection group (635 patients) had a significantly lower intracranial infection rate (2.20%) compared to routine disinfection group (367 patients, 5.72%).
Clinical Best Practices
Adopt multiple intraoperative disinfection steps targeting nasal and sinus mucosa to reduce bacterial colonization.
Perform bacteriological surveillance intraoperatively to identify and monitor bacterial presence and resistance patterns.
Stratify patients by CSF leak status to assess infection risk and tailor preventive measures.
Use standardized diagnostic criteria combining clinical symptoms, CSF biochemical analysis, and microbiological culture for early detection of intracranial infections.
